[PRNewswire] Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab
Leaders Envision the Lab of the Future
(RARITAN, New Jersey and SINGAPORE, May 8, 2018 PRNewswire=연합뉴스) Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, will host the Ortho Lab Leader Scientific Summit on May 8 and 9 at the Conrad Hotel in Seoul, South Korea.
The summit, arranged with the support of the College of American Pathologists, will be an opportunity for lab leaders in the Asia-Pacific region to gain insights from some of the brightest minds in the field of diagnostics about the latest innovations in clinical labs and transfusion medicine.
"Ortho is committed to serving as a trusted advisor to the diagnostics community around the world," said Alex Socarras, Ortho's chief commercial officer. "Diagnostics is rapidly evolving to meet increasing challenges and keep pace with medical innovation worldwide, and helping labs thrive despite the increasing pressures they face is important for us."
Expert speakers from Korea, the U.S. and Europe will cover automation, leadership and quality in the lab, acute kidney injury and cardiac biomarkers, and work practice standardization.
"This year's Lab Leader Summit continues Ortho's tradition of bringing together the most innovative thinkers in diagnostics throughout Asia, as we discuss how to address operational challenges and persistent areas of high unmet medical need," said Anand Pande, head of Ortho's Asia-Pacific region.
In March, Ortho sponsored a second annual Transfusion Medicine Summit in China [https://www.orthoclinicaldiagnostics.com/en-us/home/news-events/news/detailnews/ortho-clinical-diagnostics-to-host-transfusion-medicine-summit-in-china ]. And in July, Ortho will host its third annual "C-Suite Summit" in Singapore to address key issues of priority to senior hospital leaders.
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world, helping them run more efficiently and effectively, and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.
(c) Ortho Clinical Diagnostics 2018
Logo - https://mma.prnewswire.com/media/376902/ocd_only_black_Logo.jpg
Source: Ortho Clinical Diagnostics
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Leaders Envision the Lab of the Future
(RARITAN, New Jersey and SINGAPORE, May 8, 2018 PRNewswire=연합뉴스) Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, will host the Ortho Lab Leader Scientific Summit on May 8 and 9 at the Conrad Hotel in Seoul, South Korea.
The summit, arranged with the support of the College of American Pathologists, will be an opportunity for lab leaders in the Asia-Pacific region to gain insights from some of the brightest minds in the field of diagnostics about the latest innovations in clinical labs and transfusion medicine.
"Ortho is committed to serving as a trusted advisor to the diagnostics community around the world," said Alex Socarras, Ortho's chief commercial officer. "Diagnostics is rapidly evolving to meet increasing challenges and keep pace with medical innovation worldwide, and helping labs thrive despite the increasing pressures they face is important for us."
Expert speakers from Korea, the U.S. and Europe will cover automation, leadership and quality in the lab, acute kidney injury and cardiac biomarkers, and work practice standardization.
"This year's Lab Leader Summit continues Ortho's tradition of bringing together the most innovative thinkers in diagnostics throughout Asia, as we discuss how to address operational challenges and persistent areas of high unmet medical need," said Anand Pande, head of Ortho's Asia-Pacific region.
In March, Ortho sponsored a second annual Transfusion Medicine Summit in China [https://www.orthoclinicaldiagnostics.com/en-us/home/news-events/news/detailnews/ortho-clinical-diagnostics-to-host-transfusion-medicine-summit-in-china ]. And in July, Ortho will host its third annual "C-Suite Summit" in Singapore to address key issues of priority to senior hospital leaders.
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world, helping them run more efficiently and effectively, and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.
(c) Ortho Clinical Diagnostics 2018
Logo - https://mma.prnewswire.com/media/376902/ocd_only_black_Logo.jpg
Source: Ortho Clinical Diagnostics
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
